Literature DB >> 30286206

Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.

Hiroshi Wada, Atsushi Shimizu, Toshihiro Osada, Yuki Tanaka, Satoshi Fukaya, Eiji Sasaki.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0199249.].

Entities:  

Year:  2018        PMID: 30286206      PMCID: PMC6171946          DOI: 10.1371/journal.pone.0205567

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There are typographical errors in the fourth and fifth sentences of the Abstract. “IFN-μ” should appear as “IFN-γ.” The correct sentences are: However, to confirm whether a multivalent vaccine can induce an individual epitope-specific CTL, the only viable screening strategies currently available are interferon-gamma (IFN-γ enzyme-linked immunospot (ELISPOT) assays using human peripheral blood mononuclear cells, or expensive human leukocyte antigen (HLA)-expressing mice. In this report, we evaluated the use of our developed murine-20S immunoproteasome (i20S) digestion assay and found that it could predict the results of IFN-γ ELISPOT assays. There is a typographical error in the Abbreviations. “IFN-μΛ, interferon-gamma” should appear as “IFN-γ, interferon-gamma.”
  1 in total

1.  Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design.

Authors:  Hiroshi Wada; Atsushi Shimizu; Toshihiro Osada; Yuki Tanaka; Satoshi Fukaya; Eiji Sasaki
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.